NRIX
Nurix Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -7.1% ·
flujo de acciones +3.1% ·
nuevas posiciones netas -7.7%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +2 | 57.55M | $1.40B | +9 | −7 |
| Q1 2026 | 81 | +9 | 58.06M | $899.96M | +14 | −5 |
| Q4 2025 | 72 | -4 | 55.79M | $1.06B | — | −4 |
| Q3 2025 | 18 | +1 | 36.35M | $335.90M | +1 | — |
| Q2 2025 | 14 | -2 | 38.82M | $442.11M | — | −2 |
| Q1 2025 | 13 | 0 | 15.31M | $181.88M | +1 | −1 |
| Q4 2024 | 13 | -1 | 15.53M | $292.61M | +1 | −2 |
| Q3 2024 | 13 | -1 | 13.04M | $292.98M | +1 | −2 |
| Q2 2024 | 14 | — | 12.64M | $263.85M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.48M | +8.8% | $78.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 3.07M | +8.2% | $68.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.07M | +8.2% | $68.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | ARK Investment Management ✦ | 2.22M | -4.6% | $49.80M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.53M | +47.1% | $34.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.53M | +47.1% | $34.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 1.45M | +9.6% | $32.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasivo) | 1.45M | +9.6% | $32.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 318.80K | -37.2% | $7.16M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 290.00K | 0.0% | $6.52M | 0.0% | Held | 2 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 246.40K | -23.9% | $5.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 221.72K | -63.0% | $4.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 72.84K | Nuevo | $1.64M | 0.0% | New | 1 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 50.71K | -16.7% | $1.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 46.92K | +120.3% | $1.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 46.92K | +120.3% | $1.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 46.92K | +120.3% | $1.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Duquesne Family Office ✦ | 44.20K | 0.0% | $993,000 | 0.0% | Held | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| D. E. Shaw & Co. | $1.64M | 0.0% |
Posición cerrada
| Arrowstreet Capital | $1.25M | era 0.0% |
| Gotham Asset Management | $247,769 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 194 tenedores, 116.98M acciones, $1.75B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.